Mazanti-Andersen advised Hemab on the deal. The Denmark and US-based biotech company Hemab raised USD 135 million in oversubscribed series B financing. Access Biotechnology led the round...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here